Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Next Point Therapeutics announced it raised $33.7 Million in an initial filing from an offering of $48.7 Million

PRIVATEJul 30, 2026•10 days ago

Amount Raised

$33.7 Million

Round Type

Venture - Series Unknown

CambridgeBiotechnology

Company Information

Company

NextPoint Therapeutics

Location

238 MAIN STREET

Cambridge, Maryland, United States

About

Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on a novel, validated checkpoint axis discovered by our scientist founders. Our goal is to deliver new options to people with cancer.

Related People

Suggested for you
4 contacts
Verified contactsTatiana, Chief Scientific Officer hidden
Predictive Intelligence
Strategic

ML-powered predictions for NextPoint Therapeutics's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.